Mergers & Acquisitions
Athenahealth SVP and Chief Product Officer Paul Brient predicts telehealth visits will even out, IPOs will continue and venture eyes will remain on digital health in 2021.
Accolade intends to strengthen its ability to provide users with second opinions, using 2nd.MD's provider network.
The company says the move will enable its customers to more efficiently connect patients with lifesaving therapies.
This week's top stories include Optum and Change creating a healthcare powerhouse; Amazon, Berkshire Hathaway and JPMorgan Chase's joint venture calling it quits; and patient engagement tech's role in streamlining the COVID-19 vaccine rollout.
The companies pointed to the potential to reduce administrative waste, inform patient care decisions and improve payment systems across the industry.
By connecting provider and payer access points, the deal aims to make care more available, boost care coordination and improve online patient experience, says Kyruus CEO Graham Gardner.
The machine learning-powered tech will be a "key component of our go-forward analytics and digital identity strategy," says CEO Gus Malezis.
HIMSS Middle East 2020
Both will work together to accelerate the growth of transformational healthcare companies across markets in the Middle East and North African, and the Association of South-East Asian Nations.
Despite a dip in M&A activity in 2020, analysts predict the pent-up activity from the pandemic will "very likely" cause a surge in deals in 2021.
The credentialing acquisition helps strengthen its offerings for governance, risk and compliance, RLDatix says, and will lead to broader hospital deployment of its Applied Safety Intelligence Framework.